January 2026
1. MATSUNUMA R, Kinoshita K, Imada S, Sato S, et al
   CD44 knockdown and TGF?beta inhibition modulate cell proliferation and invasion in claudin?low breast cancer cells.
   Oncol Rep. 2026;55:7.
   

   >> Share

   
   
2. LI G, Jin B, Zhou J, Fang S, et al
   Immune system, inflammatory response, and regulated cell death in breast cancer research (Review).
   Oncol Rep. 2026;55:11.
   

   >> Share

   
   
3. JUNG E, Kim YJ, Lee K, Jang S, et al
   C?terminal HSP90 inhibitor NCT?58 impairs the cancer stem?like phenotype and enhances chemotherapy efficacy in TNBC.
   Oncol Rep. 2026;55:13.
   

   >> Share

   
   November 2025
4. LUO X, Wei Y, Lin H, Xiao N, et al
   BUB1B promotes homologous recombination?mediated DNA damage repair in breast cancer cells through the PI3K/AKT signaling pathway.
   Oncol Rep. 2025;54:147.
   

   >> Share

   
   
5. CHEN T, Sun S, Zhou Z, Zhang X, et al
   Ursolic acid: A natural pentacyclic triterpenoid with clinical promise in gynecological and breast cancers (Review).
   Oncol Rep. 2025;54:153.
   

   >> Share

   
   September 2025
6. LI T, Zhang C, Ding Y, Zhai W, et al
   [Corrigendum] Umbilical cord?derived mesenchymal stem cells promote proliferation and migration in MCF?7 and MDA?MB?231 breast cancer cells through activation of the ERK pathway.
   Oncol Rep. 2025;54:100.
   

   >> Share

   
   
7. CIARAMELLA V, Carrese B, Coppola L, Smaldone G, et al
   Evaluation of HMGB1 as possible marker via breast organoid cultures research.
   Oncol Rep. 2025;54:106.
   

   >> Share

   
   July 2025
8. ZUO X, Qin Y, Zhang X, Ning Q, et al
   [Retracted] Breast cancer cells are arrested at different phases of the cell cycle following the re?expression of ARHI.
   Oncol Rep. 2025;54:83.
   

   >> Share

   
   June 2025
9. XIAO L, Li J, Liao J, Wu M, et al
   BCL2A1? and G0S2?driven neutrophil extracellular traps: A protective mechanism linking preeclampsia to reduced breast cancer risk.
   Oncol Rep. 2025;53:64.
   

   >> Share

   
   March 2025
10. DU SM, Li N, Xu WJ, Liu K, et al
    Triple?negative breast cancer cell?derived piR?31115 promotes the proliferation and migration of endothelial cells via METTL3?mediated m6A modification of YAP1.
    Oncol Rep. 2025;53:34.
    

    >> Share

    
    February 2025
11. ZHANG X, Cui D, Sun W, Yang G, et al
    Regulation of the beta?catenin/LEF?1 pathway by the siRNA knockdown of RUVBL1 expression inhibits breast cancer cell proliferation, migration and invasion.
    Oncol Rep. 2025;53:22.
    

    >> Share

    
    January 2025
12. HAN R, Zhao J, Lu L
    [Retracted] MicroRNA?34a expression affects breast cancer invasion in vitro and patient survival via downregulation of E2F1 and E2F3 expression.
    Oncol Rep. 2025;53:8.
    

    >> Share

    
    
13. DAI X, Geng F, Li M, Liu M, et al
    [Corrigendum] Tripartite motif?containing 11 regulates the proliferation and apoptosis of breast cancer cells.
    Oncol Rep. 2025;53:5.
    

    >> Share

    
    
14. WANG YW, Tuan YL, Wang JY, Chang HY, et al
    Potential of epithelial membrane protein 3 as a novel therapeutic target for human breast cancer.
    Oncol Rep. 2025;53:16.
    

    >> Share

    
    December 2024
15. HU F, Zhang Y, Li M, Zhao L, et al
    [Corrigendum] BMP?6 inhibits the metastasis of MDA?MB?231 breast cancer cells by regulating MMP?1 expression.
    Oncol Rep. 2024;52:163.
    

    >> Share

    
    November 2024
16. SUN P, Huang H, Ma JC, Feng B, et al
    Repurposing propofol for breast cancer therapy through promoting apoptosis and arresting cell cycle.
    Oncol Rep. 2024;52:155.
    

    >> Share

    
    October 2024
17. CUI H, Yuan J, Du X, Wang M, et al
    [Corrigendum] Ethyl gallate suppresses proliferation and invasion in human breast cancer cells via Akt?NF?kappaB signaling.
    Oncol Rep. 2024;52:128.
    

    >> Share

    
    
18. ZHAO Z, Sun YS, Chen W, Lv LX, et al
    [Corrigendum] Hispolon inhibits breast cancer cell migration by reversal of epithelial?to?mesenchymal transition via suppressing the ROS/ERK/Slug/E?cadherin pathway.
    Oncol Rep. 2024;52:134.
    

    >> Share

    
    September 2024
19. QIU Y, Liu Y, Li WH, Zhang HQ, et al
    [Corrigendum] P2Y2 receptor promotes the migration and invasion of breast cancer cells via EMT?related genes Snail and E?cadherin.
    Oncol Rep. 2024;52:111.
    

    >> Share

    
    August 2024
20. LIM JS, Kim E, Song JS, Ahn S, et al
    Energy?stress?mediated activation of AMPK sensitizes MPS1 kinase inhibition in triple?negative breast cancer.
    Oncol Rep. 2024;52:101.
    

    >> Share

    
    
21. LI H, Li X, Du W
    Interplay between Wnt signaling molecules and exosomal miRNAs in breast cancer (Review).
    Oncol Rep. 2024;52:107.
    

    >> Share

    
    
22. PENG X, Ma L, Chen X, Tang F, et al
    Inhibition of FBP1 expression by KMT5A through TWIST1 methylation is one of the mechanisms leading to chemoresistance in breast cancer.
    Oncol Rep. 2024;52:110.
    

    >> Share

    
    July 2024
23. YAO J, Xu T, Tian T, Fu X, et al
    [Retracted] Tripartite motif 16 suppresses breast cancer stem cell properties through regulation of Gli?1 degradation via the ubiquitin?proteasome pathway.
    Oncol Rep. 2024;52:89.
    

    >> Share

    
    
24. YANG X, Liang B, Zhang L, Zhang M, et al
    Ursolic acid inhibits the proliferation of triple?negative breast cancer stem?like cells through NRF2?mediated ferroptosis.
    Oncol Rep. 2024;52:94.
    

    >> Share

    
    
25. ANWAR S, Zafar M, Hussain MA, Iqbal N, et al
    Unravelling the therapeutic potential of forkhead box proteins in breast cancer: An update (Review).
    Oncol Rep. 2024;52:92.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share